Search for: "MAJOR PHARMACEUTICALS"
Results 1 - 20
of 4,362
Sort by Relevance
|
Sort by Date
7 Jun 2024, 3:33 am
Another major legal dispute involving Novartis relates to the Federal Trade Commission’s (FTC) unsuccessful attempt to block Novant Health’s $320 million acquisition of two hospitals in North Carolina. [read post]
4 Jun 2024, 3:00 am
The case under appeal began four years ago when the city and county of Honolulu sued Sunoco and 14 other major oil and gas producers alleging a failure to warn and creating a nuisance. [read post]
31 May 2024, 10:44 am
Dennis Crouch, Major Proposed Changes to Terminal Disclaimer Practice (and You are Not Going to Like it), Patently-O (May 9, 2024). [read post]
31 May 2024, 7:48 am
Every patient deserves peace of mind when it comes to their medications, and to live free of the consequences of medical and pharmaceutical malpractice. [read post]
28 May 2024, 6:48 am
Founded in 2015, the firm focuses exclusively on healthcare, specifically the provider services, hospital/major facilities, life sciences/pharmaceutical (pharmaceutical services and contract manufacturing for medical equipment/devices) and non-reimbursement industries. [read post]
24 May 2024, 12:47 pm
The Public Health Service Act requires pharmaceutical manufacturers who participate in Medicare or Medicaid to sell certain drugs at discounted prices to select healthcare providers, like hospitals serving low-income patients. [read post]
24 May 2024, 3:00 am
National/Federal With Debate Deal, Trump and Biden Sideline a Storied Campaign Institution DNyuz – Adam Nagourney (New York Times) | Published: 5/16/2024 The agreement by President Biden and Donald Trump to move ahead with two presidential debates, and sideline the Commission on Presidential Debates, is a debilitating and potentially fatal blow to an institution that had once been a major arbiter in presidential politics. [read post]
19 May 2024, 9:56 pm
It is often reported that persons who have had major brain injuries find it challenging to do their regular tasks as they did before the disaster. [read post]
17 May 2024, 1:07 pm
On the other, it encourages generic pharmaceutical manufacturers to challenge name-brand patents while antitrust law prohibits anticompetitive deals. [read post]
15 May 2024, 6:29 am
The American Alliance of Museums (“AAM”), the Association of Art Museum Directors (“AAMD”), and the Association of Academic Museums and Galleries (“AAMG”) are a few of the major museum organizations in the US. [read post]
13 May 2024, 8:09 am
In 2023, Seeger had an unprecedented run of success, finalizing major settlements on behalf of injured plaintiffs in complex cases. [read post]
9 May 2024, 11:30 am
These are my peeps, the great majority of us gloriously unpunished for our criminal transgressions. [read post]
9 May 2024, 10:55 am
This settlement marks a crucial step in the ongoing litigation against major pharmaceutical companies over the alleged dangers of Zantac. [read post]
6 May 2024, 8:06 am
Founded in 2015, the firm focuses exclusively on healthcare, specifically the provider services, hospital/major facilities, life sciences/pharmaceutical (pharmaceutical services and contract manufacturing for medical equipment/devices) and non-reimbursement industries. [read post]
2 May 2024, 6:57 am
Alishan: Well, actually, there is a major drift in India towards alternative dispute resolution. [read post]
2 May 2024, 12:06 am
The majority of the dismissals were found by the CCMA to be fair. [read post]
28 Apr 2024, 6:16 pm
Noting this press release as it shines light into the foothold AI is gaining in major sectors, in this case, pharmaceuticals: “For over a decade, Moderna has been at the intersection of science, technology and health. [read post]
25 Apr 2024, 12:52 am
The majority of the dismissals were found by the CCMA to be fair. [read post]
25 Apr 2024, 12:52 am
The majority of the dismissals were found by the CCMA to be fair. [read post]
24 Apr 2024, 9:27 pm
The majority opinion raises issues in its invalidity analysis regarding the extent to which the prior art should be required to disclose the recited administered dose to satisfy the "reasonable expectation of success" prong for obviousness for pharmaceutical claims (wherein the standard... [read post]
